Researchers help identify mechanisms by which multiple myeloma escapes targeted immunotherapy
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine,…
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine,…
The European Commission (EC) has granted the approval of a type II variation application for…
An experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially…